HQL abrdn Life Sciences Investors: institutional ownership and insider trading
86 funds reported holding $157M of abrdn Life Sciences Investors in their latest 13F filings; in Q2 2026 funds net sold $8.43M, with 7 new positions and 11 funds selling out; over the last 12 months insiders bought $144K and sold $0 on the open market.
Famous investors holding HQL
- Ken Griffin (Citadel Advisors): $287K, 0.0% of the portfolio
Largest institutional holders of HQL
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $35.5M
- Penserra Capital Management LLC — $16.8M
- RAYMOND JAMES FINANCIAL INC (RJF, RJF-PB) — $13.8M
- LPL Financial LLC — $10.3M
- Allspring Global Investments Holdings, LLC — $9.11M
- NEEDHAM INVESTMENT MANAGEMENT LLC — $8.87M
- FLAGSHIP HARBOR ADVISORS, LLC — $8.02M
- AMERIPRISE FINANCIAL INC (AMP) — $3.91M
- Advisors Asset Management, Inc. — $3.40M
- 180 WEALTH ADVISORS, LLC — $3.06M
Recent HQL insider trades
- Jul 16, 2026: Mahai Chris LaVictoire bought 527 shares ($10.5K)
- Dec 16, 2025: Pittard Christian bought 7,923 shares ($134K)
- Sep 22, 2025: Saba Capital Management, L.P. sold 48,612 shares ($687K)
- Sep 18, 2025: Saba Capital Management, L.P. sold 64,536 shares ($906K)
5%+ owners
- First Trust Portfolios L.P.: 11.3% (Schedule 13G/A, filed Oct 14, 2026)